Active Biotech (Stockholm: ACTI.ST) management is scheduled to present at the Rodman & Renshaw Annual Global Healthcare Conference next week on Tuesday, May 16 at 2:40 pm CEST (8:40 am EDT) in Monaco. During the presentation, management will provide an update on the Active Biotech development program as well as a description of the recently signed partnership agreement with Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) regarding the I-3D project.
